Back to 
Centiva Capital, LP
Centiva Capital, LP
AKBA
2 quarters
Position history for Centiva Capital, LP's holdings in Akebia Therapeutics, Inc.
No. Centiva Capital exited its AKBA (Akebia Therapeutics) position in Q3 2022. Its Q2 2022 13F listed 13,638 shares worth $5,000. Centiva Capital first reported AKBA in Q2 2022 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$5,000
Total Shares Change
-13,638
Quarter-by-Quarter History
Other major holders of AKBA: Baupost Group LLC